What are the dosage options for cytarabine in the treatment of acute myeloid leukemia (AML)?

Updated: May 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Mayer et al conducted a randomized study of three different doses of cytarabine in patients with AML who achieved remission after standard 3 and 7 induction chemotherapy. [50] Patients received four courses of cytarabine at one of the following dosages:

  • 100 mg/m 2/d by continuous infusion for 5 days
  • 400 mg/m 2/d by continuous infusion for 5 day
  • 3 g/m 2 in a 3-hour infusion every 12 hours on days 1, 3, and 5

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!